Frontiers in Anti-Infective Agents: Volume 5 (PDF Book)
Anti-infective agents are a distinct class of pharmacologically important molecules that have served mankind in different capacities to combat life-threatening pathological conditions. They include antibacterial, antifungal, antiviral, antituberculosis, antimalarial and urinary anti-infective agents. However, evolutionary changes, adaptations and development of new strains of pathogenic microorganisms that have reduced the therapeutic efficacy of existing drugs, thus, limiting their clinical utility over the years. Frontiers in Anti-Infective Agents Volume 5 is a collection of notable research efforts, successful anti-infective drug development programmes and a comprehensive overview of successful and unsuccessful clinical trials in this domain. The volume covers interesting topics: 1) the treatment of acute wounds with the vikut® formula, 2) anti-infective treatment of ocular diseases and 3) sars-cov vaccine development and antimicrobial therapy for SARS symptoms. A chapter summarizing recent anti-infective approaches rounds up the contents of this volume. This book is a timely reference for postgraduate scholars and researchers seeking updates in specific areas of anti-infective drug development. Allied healthcare professionals (clinical and public healthcare professionals) can also benefit from the information presented within.
Product Details
- Publisher: Bentham Science Publishers; September 14, 2021
- Language: English
- ISBN: 9814998397
- ISBN: 9789814998406

Epidemiology of Thyroid Disorders (EPUB)
Dilemma's bij dementie
Partial Knee Arthroplasty
Mechanical Ventilation in Emergency Medicine
Adolescents with Chronic Kidney Disease
Practical Manual of Histology (PDF)
Supporting Sucking Skills In Breastfeeding Infants 2nd
Absolute Obstetric Anesthesia Review: The Complete Study Guide for Certification and Recertification
Bildgebung des Thorax bei Neugeborenen und Kleinkindern
Advances in Psychiatry 1st ed. 2019 Edition
The Pharmacist Guide to Implementing Pharmaceutical Care
Head and Neck Cancer: An Evidence-Based Team Approach 

